13434-13-4 AKTINONIN
| Ürün Adı |
AKTINONIN |
| Eş anlamlı |
;(-)-ACTINONIN; 3-[[1-[[2-(HIDROKSIMETIL)-1-PIROLIDINIL]KARBONIL]-2-METIL-PROPIL]KARBAMOIL]OKTANOHIDROKSAMIK ASIT; 3-[[1-[[2-(HIDROKSIMETIL)-1-PIROLIDINIL]-KARBONIL]-2-METILPROPIL]-KARBAMOIL]-OKTONOHIDROKSAMIK ASIT; hylpropyl)karbamoil)-; oktanohidroksamik asit, 3-((1-((2-(hidroksimetil)-1-pirolidinil)karbonil)-2-met; N4-Hidroksi-N1-[(1S)-1[[(2S)-2-(hidroksimetil)-1-piroldinil]karbonil]-2-metilpropil]-2-pentil-,(2R)-(9CI); N ~ 4 ~ - hidroksi-N ~ 1 ~ - {1- [2- (hidroksimetil) pirolidin-1-il] -3-metil-1-oksobutan-2-il}-2-pentilbütandiamid; (2R) -N ~ 4 ~ -hidroksi-N ~ 1 ~ - {(2S) -1 - [(2S) -2- (hidroksimetil) pirolidin-1-il] -3-metil-1-oksobutan-2-il}-2-pentilbütandiamid;
|
| ingilizce adı |
ACTINONIN; (-)-ACTINONIN; 3-[[1-[[2-(HYDROXYMETHYL)-1-PYRROLIDINYL]CARBONYL]-2-METHYL-PROPYL]CARBAMOYL]OCTANOHYDROXAMIC ACID; 3-[[1-[[2-(HYDROXYMETHYL)-1-PYRROLIDINYL]-CARBONYL]-2-METHYLPROPYL]-CARBAMOYL]-OCTONOHYDROXAMIC ACID; hylpropyl)carbamoyl)-; octanohydroxamicacid,3-((1-((2-(hydroxymethyl)-1-pyrrolidinyl)carbonyl)-2-met; N4-Hydroxy-N1-[(1S)-1[[(2S)-2-(hydroxymethyl)-1-pyrroldinyl]carbonyl]-2-methylpropyl]-2-pentyl-,(2R)-(9CI); N~4~-hydroxy-N~1~-{1-[2-(hydroxymethyl)pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl}-2-pentylbutanediamide; (2R)-N~4~-hydroxy-N~1~-{(2S)-1-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl}-2-pentylbutanediamide |
| Moleküler Formülü |
C19H35N3O5 |
| Molekül Ağırlığı |
385.4983 |
| InChI |
InChI=1/C19H35N3O5/c1-4-5-6-8-14(11-16(24)21-27)18(25)20-17(13(2)3)19(26)22-10-7-9-15(22)12-23/h13-15,17,23,27H,4-12H2,1-3H3,(H,20,25)(H,21,24)/t14-,15+,17+/m1/s1 |
| CAS kayıt numarası |
13434-13-4 |
| Moleküler Yapısı |
|
| Yoğunluk |
1.139g/cm3 |
| Kırılma indisi |
1.513 |
| Tehlike Sembolleri |
|
| Risk Kodları |
|
| Güvenlik Açıklaması |
S22-24/25:;
|
|
TR
CN
CZ
DE
EN
ES
FR
GR
HU
ID
IL
IN
IR
IT
JP
KR
MY
NL
NO
PL
PT
RU
SA
